Niva Bupa Health Insurance to Host Q2FY26 Earnings Call on November 3

1 min read     Updated on 28 Oct 2025, 07:16 PM
scanx
Reviewed by
Riya DeyScanX News Team
Overview

Niva Bupa Health Insurance Company Limited has scheduled an earnings call on November 3, 2025, at 18:30 IST to discuss Q2FY26 and H1FY26 unaudited financial results. Key executives, including the MD & CEO and CFO, will participate. The call will be hosted by ICICI Securities, with universal access numbers provided for India and toll-free numbers for international participants. The company's Board of Directors will meet on the same day to approve the results. The trading window for Designated Persons will remain closed until November 5, 2025.

23204797

*this image is generated using AI for illustrative purposes only.

Niva Bupa Health Insurance Company Limited has announced its upcoming earnings call to discuss the unaudited financial results for the quarter and half year ended September 30, 2025. The call is scheduled for November 3, 2025, at 18:30 IST, providing investors and analysts an opportunity to gain insights into the company's performance.

Key Details of the Earnings Call

Aspect Details
Date November 3, 2025
Time 18:30 IST
Host ICICI Securities
Purpose Discussion of Q2FY26 and H1FY26 unaudited financial results

Executive Participation

The call will feature key executives from Niva Bupa Health Insurance, including:

  • Mr. Krishnan Ramachandran, Managing Director & CEO
  • Mr. Vishwanath Mahendra, Executive Director & CFO
  • Mr. Ankur Kharbanda, Executive Director & Chief Business Officer
  • Mr. Bhabatosh Mishra, Chief Operating Officer
  • Mr. Dhiresh Rustogi, Chief Technology Officer
  • Mr. Vikas Jain, Chief Investment Officer

Access Information

For those interested in participating, Niva Bupa has provided multiple access options:

Region Access Number
Universal Access (India) +91 22 6280 1144 / +91 22 7115 8045
Singapore (Toll Free) 8001012045
Hong Kong (Toll Free) 800964448
UK (Toll Free) 08081011573
USA (Toll Free) 18667462133

Additional Information

The company has also announced that its Board of Directors is scheduled to meet on the same day, November 3, 2025, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025.

In line with regulatory requirements, Niva Bupa has informed that the trading window for Designated Persons and their immediate relatives will remain closed until November 5, 2025 (inclusive).

Investors and analysts looking for further details or clarifications regarding the earnings call can contact the designated ICICI Securities representatives mentioned in the company's official communication.

This earnings call presents an opportunity for stakeholders to gain valuable insights into Niva Bupa Health Insurance's financial performance and future outlook in the health insurance sector.

Historical Stock Returns for Niva Bupa Health Insurance Company

1 Day5 Days1 Month6 Months1 Year5 Years
-0.74%-2.21%-10.99%-10.07%+0.03%+0.03%
Niva Bupa Health Insurance Company
View in Depthredirect
like20
dislike

Niva Bupa Triumphs in ₹1,241 Crore GST Demand Case

1 min read     Updated on 01 Oct 2025, 05:27 PM
scanx
Reviewed by
Riya DeyScanX News Team
Overview

Niva Bupa Health Insurance Company Limited has won a significant GST demand case worth ₹1,241.00 crore. The Additional Commissioner of Central Goods & Service Tax, Meerut, ruled in favor of Niva Bupa, dropping proceedings on alleged non-payment of GST on co-insurance premium and reinsurance commission from July 2017 to March 2022. The case, initially raised by the Office of Principal Commissioner CGST and Central Excise, Pune Zonal unit, was remanded by the Bombay High Court for fresh consideration. Niva Bupa confirmed no impact on its financial, operational, or other activities due to this decision.

20865462

*this image is generated using AI for illustrative purposes only.

Niva Bupa Health Insurance Company Limited has emerged victorious in a significant GST demand case, marking a substantial win for the company in its regulatory compliance efforts.

Case Resolution

The Additional Commissioner of Central Goods & Service Tax, Meerut, has ruled in favor of Niva Bupa, effectively closing proceedings on a GST demand case worth ₹1,241.00 crore. This decision comes as a relief to the company, which had been contesting the allegations of non-payment of GST on two fronts:

  1. Co-insurance premium from July 2017 to March 2022
  2. Reinsurance commission for the same period

Legal Journey

The case has traversed a complex legal path:

  1. Initially, the Office of Principal Commissioner CGST and Central Excise, Pune Zonal unit, had raised the demand.
  2. The matter was then heard by the Hon'ble High Court of Bombay, which set aside the original order and remanded the case back for fresh consideration.
  3. Subsequently, the case was transferred to the Principal Commissioner Central Goods & Service Tax, Meerut.

Final Verdict

On September 30, 2025, at 07:18 P.M., Niva Bupa received the final order from the Additional Commissioner. The order states that the proceedings and alleged demand against the company have been dropped, in light of the directive passed by the Hon'ble Court.

Impact on Niva Bupa

The resolution of this case is significant for Niva Bupa for several reasons:

  1. Financial Relief: The dropped proceedings mean that Niva Bupa will not have to pay the substantial sum of ₹1,241.00 crore that was initially demanded.
  2. Operational Continuity: The company has confirmed that there will be no impact on its financial, operational, or other activities as a result of this decision.
  3. Regulatory Compliance: This outcome reinforces Niva Bupa's stance on its GST compliance during the period in question.

Corporate Disclosure

In compliance with regulatory requirements, Niva Bupa has made the necessary disclosures to the National Stock Exchange of India Limited and BSE Limited. The company has provided detailed information as mandated under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This favorable resolution for Niva Bupa underscores the importance of due process in regulatory matters and highlights the company's successful navigation of a complex GST-related challenge.

Historical Stock Returns for Niva Bupa Health Insurance Company

1 Day5 Days1 Month6 Months1 Year5 Years
-0.74%-2.21%-10.99%-10.07%+0.03%+0.03%
Niva Bupa Health Insurance Company
View in Depthredirect
like17
dislike
More News on Niva Bupa Health Insurance Company
Explore Other Articles